BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10932511)

  • 61. [Diane].
    Hansted B; Reymann F
    Ugeskr Laeger; 1983 Aug; 145(31):2391-2. PubMed ID: 6623686
    [No Abstract]   [Full Text] [Related]  

  • 62. [Sequence therapy with estradiol valerate-norgestrel at menopause. A double-blind investigation].
    Davidsen PC; Secher NJ; Pedersen GT; Christensen NC
    Ugeskr Laeger; 1974 Aug; 136(32):1805-8. PubMed ID: 4605940
    [No Abstract]   [Full Text] [Related]  

  • 63. Lipoprotein levels following treatment with cyproterone acetate or LHRH analogues.
    Gillatt DA; Bolton CH; Chadwick D; Downs LG; Hopton MI; Gingell JC
    Br J Urol; 1993 Jun; 71(6):728-30. PubMed ID: 8343902
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women.
    Sauerbronn AV; Fonseca AM; Bagnoli VR; Saldiva PH; Pinotti JA
    Int J Gynaecol Obstet; 2000 Jan; 68(1):35-41. PubMed ID: 10687834
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antiaggressive effect of cyproterone versus haloperidol in Alzheimer's disease: a randomized double-blind pilot study.
    Huertas D; López-Ibor Aliño JJ; Molina JD; Chamorro L; Balanza J; Jiménez MP; Hornillos M
    J Clin Psychiatry; 2007 Mar; 68(3):439-44. PubMed ID: 17388716
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Failure to induce sterility in male rats with continuously released micro-quantities of cyproterone acetate and norgestrel.
    Elger W; Berswordt-Wallrabe R VO
    Acta Endocrinol Suppl (Copenh); 1973; 173():120. PubMed ID: 4542060
    [No Abstract]   [Full Text] [Related]  

  • 67. [Cyproterone therapy of papulopustular rosacea in women].
    Mauss J
    Hautarzt; 1981 Feb; 32(2):94-5. PubMed ID: 6453108
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Norgestrel may be a potential therapy for retinal degenerations.
    Doonan F; Cotter TG
    Expert Opin Investig Drugs; 2012 May; 21(5):579-81. PubMed ID: 22375616
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of cyproterone acetate, d-norgestrel and progesterone on the canine mammary gland.
    El Etreby MF; Wrobel KH
    Cell Tissue Res; 1978 Nov; 194(2):245-67. PubMed ID: 728963
    [No Abstract]   [Full Text] [Related]  

  • 70. [Cyproterone (Androcur), a hormone with antiandrogenic effect].
    Dein E
    Ugeskr Laeger; 1975 Jul; 137(27):1547-8. PubMed ID: 1145868
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hormone replacement therapy and uterine leiomyomas].
    Porozhanova V; Bozhinova S; Khristova V
    Akush Ginekol (Sofiia); 2001; 42(2):6-9. PubMed ID: 11799759
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Estrogen-progesterone replacement therapy in the postmenopause with cyproterone acetate, an antiandrogen progestin].
    Presl J
    Ceska Gynekol; 1995 Apr; 60(2):98-101. PubMed ID: 7767599
    [No Abstract]   [Full Text] [Related]  

  • 73. Cyproterone acetate for severe hirsutism?
    Drug Ther Bull; 1981 Dec; 19(25):99-100. PubMed ID: 7297427
    [No Abstract]   [Full Text] [Related]  

  • 74. [Breast development with drug therapy in male pseudohermaphroditism].
    Zara C; Nava C; Montanari L; Polatti F
    Minerva Ginecol; 1982 Apr; 34(4):265-9. PubMed ID: 7099478
    [No Abstract]   [Full Text] [Related]  

  • 75. Results of a multicentre trial of Postinor.
    Seregély G
    Ther Hung; 1982; 30(2):72-8. PubMed ID: 6765331
    [No Abstract]   [Full Text] [Related]  

  • 76. [Not Available].
    Glauser M
    Rev Med Suisse; 2020 May; 16(694):1066. PubMed ID: 32432431
    [No Abstract]   [Full Text] [Related]  

  • 77. [Separation and identification of impurities in Chinese norgestrel].
    Fang XG; Song YW
    Yao Xue Xue Bao; 1987 Sep; 22(9):690-3. PubMed ID: 3445761
    [No Abstract]   [Full Text] [Related]  

  • 78. Comparison of norgestrel- versus cyproterone acetate-containing hormone replacement therapy on lipid-lipoprotein metabolism.
    Panyakhamlerd K; Limpaphayom K; Taechakraichana N; Chaikittisilpa S; Pasatrat S; Pojanasopanakun S
    J Med Assoc Thai; 2000 Jul; 83(7):764-70. PubMed ID: 10932511
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2002 Apr; 16(2):155-62. PubMed ID: 12012627
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.